Artwork

Sisällön tarjoaa Proactive Investors. Proactive Investors tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Player FM - Podcast-sovellus
Siirry offline-tilaan Player FM avulla!

BioHarvest Sciences Q2 Revenue Surpasses $6 Million; CEO Discusses Growth and New Product Success

6:48
 
Jaa
 

Manage episode 436900529 series 2891889
Sisällön tarjoaa Proactive Investors. Proactive Investors tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
BioHarvest Sciences CEO Ilan Sobel joined Steve Darling from Proactive to discuss the company’s impressive financial and operational results for the second quarter of 2024. For the first time, BioHarvest Sciences reported revenue surpassing the $6 million mark, reaching $6.03 million. This represents a 119% increase compared to the $2.8 million reported in the same quarter the previous year, and a 13% sequential growth from the first quarter of 2024. Sobel highlighted that the company's gross margins improved to 52% in the second quarter, up from 40% in the same period the previous year. This improvement is attributed to ongoing margin optimization efforts. In the U.S., total subscribers to the VINIA® product line increased by 135% compared to the same quarter in the previous year. A major contributor to this growth was the VINIA business, which set a new record for monthly sales orders in May 2024, achieving $2 million in sales—a 101% increase compared to May 2023. The company anticipates that revenues in the third quarter of 2024 will be at least $6.5 million. Additionally, Sobel shared exciting news about the company's VINIA® Superfood Coffee and Decaf Coffee. This "functional" coffee product line, which integrates BioHarvest's VINIA Red Grape Superfood into a premium coffee in Keurig-compatible pod format, has surpassed $1 million in cumulative sales since its launch in December 2023. The company is also planning to introduce new Nespresso-compatible pods before the end of the year, further expanding its product offerings and market reach. #proactivinvestors #cse #bhsc #otcqb #cnvcf #pharma #biotech #hearthealth #BioHarvestSciences, #IlanSobel, #RevenueGrowth, #NasdaqListing, #FinancialResults, #MarketingEfficiency, #ProductLaunch, #CoffeeProducts, #TeaProducts, #BusinessGrowth, #InvestorInterest, #BusinessStrategy, #FinancialForecast, #MarketExpansion, #CorporateDevelopment, #ManagementFocus, #EarningsReport, #StockMarket, #InvestmentOpportunity, #CorporateNews
  continue reading

611 jaksoa

Artwork
iconJaa
 
Manage episode 436900529 series 2891889
Sisällön tarjoaa Proactive Investors. Proactive Investors tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
BioHarvest Sciences CEO Ilan Sobel joined Steve Darling from Proactive to discuss the company’s impressive financial and operational results for the second quarter of 2024. For the first time, BioHarvest Sciences reported revenue surpassing the $6 million mark, reaching $6.03 million. This represents a 119% increase compared to the $2.8 million reported in the same quarter the previous year, and a 13% sequential growth from the first quarter of 2024. Sobel highlighted that the company's gross margins improved to 52% in the second quarter, up from 40% in the same period the previous year. This improvement is attributed to ongoing margin optimization efforts. In the U.S., total subscribers to the VINIA® product line increased by 135% compared to the same quarter in the previous year. A major contributor to this growth was the VINIA business, which set a new record for monthly sales orders in May 2024, achieving $2 million in sales—a 101% increase compared to May 2023. The company anticipates that revenues in the third quarter of 2024 will be at least $6.5 million. Additionally, Sobel shared exciting news about the company's VINIA® Superfood Coffee and Decaf Coffee. This "functional" coffee product line, which integrates BioHarvest's VINIA Red Grape Superfood into a premium coffee in Keurig-compatible pod format, has surpassed $1 million in cumulative sales since its launch in December 2023. The company is also planning to introduce new Nespresso-compatible pods before the end of the year, further expanding its product offerings and market reach. #proactivinvestors #cse #bhsc #otcqb #cnvcf #pharma #biotech #hearthealth #BioHarvestSciences, #IlanSobel, #RevenueGrowth, #NasdaqListing, #FinancialResults, #MarketingEfficiency, #ProductLaunch, #CoffeeProducts, #TeaProducts, #BusinessGrowth, #InvestorInterest, #BusinessStrategy, #FinancialForecast, #MarketExpansion, #CorporateDevelopment, #ManagementFocus, #EarningsReport, #StockMarket, #InvestmentOpportunity, #CorporateNews
  continue reading

611 jaksoa

Toate episoadele

×
 
Loading …

Tervetuloa Player FM:n!

Player FM skannaa verkkoa löytääkseen korkealaatuisia podcasteja, joista voit nauttia juuri nyt. Se on paras podcast-sovellus ja toimii Androidilla, iPhonela, ja verkossa. Rekisteröidy sykronoidaksesi tilaukset laitteiden välillä.

 

Pikakäyttöopas